Skip to content

Clinical trials

Phase 2 Kidney Failure, Chronic trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Kidney Failure, Chronic Phase: Phase 2 Country / region: United Kingdom Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20052
20065
20071
20091
20131
20141
20162
20192
20211
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated3
Recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Affymax4
Ineos Healthcare Limited3
Sanifit Therapeutics S. A.2
Ardelyx1
Barts & The London NHS Trust1
Celgene1
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company1
Eledon Pharmaceuticals1
Hansa Biopharma AB1
Novo Nordisk A/S1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Kidney Failure, Chronic19
Renal Insufficiency, Chronic7
Anemia6
Hyperphosphatemia3
Calcinosis2
Cardiovascular Diseases2
Calciphylaxis1
Calcium Metabolism Disorders1
Cardiovascular Abnormalities1
Diabetes Mellitus1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.